Medtech companies are not that “interested” in M&A anymore, according to a survey taken during a recent MD+DI webinar discussing Medtech Trends and Adaptation. Arda Ural, Phd, a partner, transaction advisory services practice for Ernst and Young (EY) was the presenter for the webinar.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,